| Ticker Details |
|
Pulmonx Corporation
|
| IPO Date: |
October 1, 2020 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$65.47M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.50 | 3.13%
|
| Avg Daily Range (30 D): |
$0.05 | 3.38%
|
| Avg Daily Range (90 D): |
$0.06 | 3.79%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.43M |
| Avg Daily Volume (90 D): |
.45M |
| Trade Size |
| Avg Trade Size (Sh.): |
97 |
| Avg Trade Size (Sh.) (30 D): |
151 |
| Avg Trade Size (Sh.) (90 D): |
146 |
| Institutional Trades |
| Total Institutional Trades: |
994 |
| Avg Institutional Trade: |
$1.66M |
| Avg Institutional Trade (30 D): |
$.91M |
| Avg Institutional Trade (90 D): |
$.91M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.62M |
| Avg Closing Trade (30 D): |
$1.01M |
| Avg Closing Trade (90 D): |
$1.01M |
| Avg Closing Volume: |
66.97K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-1.3
|
$-.33
|
$-.25
|
|
Diluted EPS
|
$-1.3
|
$-.33
|
$-.25
|
|
Revenue
|
$88.55M
|
$20.59M
|
$22.6M
|
|
Gross Profit
|
$66.84M
|
$16.04M
|
$17.54M
|
|
Net Income / Loss
|
$-53.21M
|
$-13.65M
|
$-10.43M
|
|
Operating Income / Loss
|
$-52.06M
|
$-12.96M
|
$-9.9M
|
|
Cost of Revenue
|
$21.7M
|
$4.54M
|
$5.06M
|
|
Net Cash Flow
|
$-12.98M
|
$-8.18M
|
$-6.8M
|
|
PE Ratio
|
|
|
|
|
|
|